// App-Quantinova.ai

AB0460 (2018) : Long-term drug survival of etanercept vs other tnf inhibitor therapies in patients with rheumatoid arthritis

Researchers

Presenter

  • P. Emery

Principal Investigators

  • B. Vlahos

  • P. Szczypa

  • M. Thakur

  • H.E. Jones

  • J. Woolcott

  • P.V. Santos Estrella

  • A. Gibofsky

  • C. Rolland

  • G. Citera

  • L. Marshall

Medical Centers

  • Leeds Musculoskeletal Biomedical Research Centre LTHT, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK

  • Pfizer, Collegeville

  • Pfizer Ltd, Walton Oaks

  • Pfizer Ltd, Sandwhich, UK

  • Weill Medical College, New York,

  • Envision Pharma Group, Horsham, UK

  • Consultorios Reumatologicos, Buenos Aires, Argentina

Locations

  • United Kingdom

  • United States

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved